Showing results (241-250 of 275) with videos related to
Sort By:
Pageof 28
Annals of the American Thoracic Society|February 10, 2018
Whole Blood Gene Expression Profiling Predicts Severe Morbidity and Mortality in Cystic Fibrosis: A 5-Year Follow-Up StudyMilene T Saavedra, Bradley S Quon, Anna Faino, et al.The Journal of Clinical Investigation|March 28, 2023
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persistDavid P Nichols, Sarah J Morgan, Michelle Skalland, et al.Plos One|September 13, 2011
Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTRRobert L Young, Kenneth C Malcolm, Jennifer E Kret, et al.Elife|June 20, 2018
Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gutAspen T Reese, Eugenia H Cho, Bruce Klitzman, et al.Annals of the American Thoracic Society|September 17, 2025
Long-term Reductions in Inflammation in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/IvacaftorScott D Sagel, T Spencer Poore, Brandie D Wagner, et al.Contemporary Clinical Trials|November 18, 2024
Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST studyJill Maggs, Gregory S Sawicki, Callie Bacon, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 16, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosisScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.Plos One|May 5, 2022
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trialSilvia M Caceres, Linda A Sanders, Noel M Rysavy, et al.Annals of the American Thoracic Society|January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study DesignNicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.Pageof 28